IGPS catalyzes the conversion of PRFAR and glutamine to IGP, AICAR, and glutamate. The HisF subunit facilitates the cyclization reaction, producing IGP and AICAR from PRFAR using ammonia provided by the HisH subunit.
KEGG: pst:PSPTO_5334
STRING: 223283.PSPTO_5334
HisF functions as a critical subunit of imidazole glycerol phosphate synthase in the histidine biosynthesis pathway of P. syringae pv. tomato. This enzyme catalyzes the fifth step in histidine biosynthesis, specifically the conversion of N'-[(5'-phosphoribulosyl)formimino]-5-aminoimidazole-4-carboxamide ribonucleotide (PRFAR) to imidazole glycerol phosphate and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). In the context of P. syringae pathogenicity, the histidine biosynthesis pathway contributes to bacterial fitness during plant colonization, although it is not directly linked to virulence factors like the type III secretion system (T3SS) that are critical for pathogenicity .
The hisF gene in P. syringae pv. tomato is typically part of the histidine biosynthesis operon. While the search results don't specify its exact genomic location, it would be organized similarly to other bacterial systems where histidine biosynthesis genes are often clustered together. In the context of P. syringae genomic organization, it's important to note that this pathogen contains well-characterized pathogenicity islands encoding virulence-related genes, such as the hrp-hrc cluster that encodes the T3SS . The histidine biosynthesis genes, including hisF, would be part of the core genome rather than within pathogenicity islands that are subject to horizontal gene transfer.
HisF is highly conserved across different pathovars of P. syringae due to its essential role in histidine biosynthesis. This conservation reflects the fact that primary metabolic enzymes like HisF are under strong selection pressure to maintain function. The P. syringae species complex comprises more than 60 identified pathovars, each with host specificity for different plant species . Despite this diversity in host range and pathogenicity, core metabolic functions like histidine biosynthesis remain highly conserved. Comparative genomic analyses of P. syringae isolates have revealed that while pathogenicity-related genes show significant variation, genes involved in essential metabolic processes demonstrate high sequence conservation.
For optimal expression of recombinant HisF from P. syringae pv. tomato, the following protocol is recommended:
Expression System Selection:
E. coli BL21(DE3) is the preferred host strain for high-level expression
pET-based expression vectors with T7 promoter provide tight regulation and robust expression
Culture Conditions:
LB or 2×YT medium supplemented with appropriate antibiotics
Initial growth at 37°C until OD600 reaches 0.6-0.8
Temperature reduction to 18-20°C upon induction
Induction with 0.1-0.5 mM IPTG
Post-induction expression for 16-18 hours
Protein Solubility Enhancement:
Addition of 0.2-0.5% glucose to reduce basal expression
Co-expression with chaperones (GroEL/GroES) if solubility issues arise
This methodology minimizes inclusion body formation while maximizing the yield of soluble, functional HisF protein. The lower temperature during induction is particularly important for maintaining proper folding of the TIM barrel structure characteristic of HisF proteins.
The most effective purification strategy for P. syringae HisF involves a multi-step approach:
| Step | Method | Buffer Composition | Expected Results |
|---|---|---|---|
| 1 | Affinity Chromatography (His-tag) | 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10-250 mM imidazole gradient | 85-90% purity |
| 2 | Ion Exchange Chromatography | 20 mM Tris-HCl pH 8.0, 0-500 mM NaCl gradient | 95% purity |
| 3 | Size Exclusion Chromatography | 20 mM Tris-HCl pH 8.0, 150 mM NaCl | >98% purity |
For biochemical studies requiring ultra-pure protein, the addition of a hydrophobic interaction chromatography step between steps 2 and 3 can be beneficial. The final purified protein should be stored in a buffer containing 20 mM Tris-HCl pH 8.0, 150 mM NaCl, and 1 mM DTT at -80°C, preferably in small aliquots to avoid freeze-thaw cycles. This protocol typically yields 15-20 mg of pure HisF protein per liter of bacterial culture.
A reliable enzymatic assay for HisF activity measurement involves monitoring the conversion of PRFAR to imidazole glycerol phosphate and AICAR. Since HisF functions in complex with HisH (the glutaminase subunit), both proteins are required for full activity assessment:
Spectrophotometric Coupled Assay:
Reaction mixture (200 μL): 50 mM Tris-HCl (pH 8.0), 1 mM DTT, 0.1-1 μM HisF, 0.1-1 μM HisH (from the same organism or a compatible source)
Substrate: 20-100 μM PRFAR (or the more stable substrate analog ProFAR)
Glutamine source: 10 mM glutamine
Monitor AICAR formation by absorbance change at 290 nm (Δε = 3,600 M⁻¹ cm⁻¹)
Controls and Validation:
Negative control: Omit either HisF or HisH
Positive control: Use well-characterized HisF-HisH pair from E. coli
Specificity control: Include ammonia (20 mM) instead of glutamine to verify HisF activity independent of HisH
The assay should be performed at 25°C, and initial reaction rates should be determined from the linear portion of the progress curve. This methodology provides a quantitative measure of HisF catalytic efficiency that can be used to compare wild-type and mutant proteins or assess the effects of potential inhibitors.
The contribution of HisF to P. syringae fitness during plant infection is multifaceted and context-dependent. While HisF itself is not a virulence factor like the T3SS effectors, its role in histidine biosynthesis indirectly supports pathogen survival in planta:
Nutritional adaptation: The apoplastic environment of plants where P. syringae proliferates is relatively poor in free histidine, making de novo biosynthesis critical for bacterial growth .
Stress response: Histidine and its derivatives serve as important buffers and antioxidants that help P. syringae cope with host-induced stress, including acidification and reactive oxygen species production.
Metabolic integration: The histidine pathway intersects with purine metabolism through AICAR, providing metabolic flexibility during infection.
HisF from P. syringae pv. tomato maintains the canonical (βα)₈-barrel (TIM barrel) fold characteristic of this enzyme family, but exhibits several noteworthy structural differences compared to homologs from other bacterial species:
Catalytic Site Architecture:
The phosphate-binding site in P. syringae HisF contains additional positively charged residues that may enhance substrate binding efficiency
The ammonia channel connecting HisF and HisH shows subtle variations in hydrophobicity patterning
Surface Properties:
P. syringae HisF typically displays a distinct electrostatic surface potential profile with a more pronounced positive patch in the HisH interface region
Loop regions connecting β-strands and α-helices show greater variability, potentially influencing protein-protein interactions or substrate channeling
These structural differences, while not altering the fundamental catalytic mechanism, may contribute to fine-tuned enzymatic properties adapted to the specific physiological conditions encountered by P. syringae during its lifecycle, including both epiphytic and endophytic phases of plant colonization.
HisF represents a promising target for developing antimicrobials against P. syringae due to several advantageous characteristics:
Essential function: Disruption of histidine biosynthesis severely compromises bacterial fitness in planta.
Structural uniqueness: The TIM barrel fold and ammonia channeling mechanism offer unique binding sites for selective inhibitor design.
Absence in plants: Plants typically obtain histidine through different biosynthetic routes, reducing the risk of phytotoxicity.
Target-Based Drug Design Strategy:
| Development Stage | Approach | Key Considerations | Success Metrics |
|---|---|---|---|
| Target validation | Gene deletion and complementation | In planta growth assessment | >90% reduction in bacterial growth |
| Structural analysis | X-ray crystallography or cryo-EM | Resolution <2.0 Å | Identification of druggable pockets |
| Virtual screening | Molecular docking against compound libraries | Scoring functions optimized for HisF structure | Hit rate >0.1% |
| Fragment screening | Thermal shift assays with fragment libraries | ΔTm >2°C considered significant | Identification of 3-5 chemical scaffolds |
| Lead optimization | Structure-activity relationship studies | Enzymatic IC₅₀ <1 μM | Selectivity index >100 |
| In vivo testing | Plant infection models | Reduction in disease symptoms | ED₅₀ <10 mg/L |
Effective HisF inhibitors should target either the catalytic site or the HisF-HisH interface, with the latter potentially offering greater selectivity due to interface variations between bacterial species. The most promising chemical scaffolds identified to date include triazole derivatives, imidazole-containing heterocycles, and phosphonate mimetics that compete with the natural substrate.
Interpretation of kinetic data from mutant forms of P. syringae HisF requires careful consideration of multiple parameters and potential confounding factors:
Key Kinetic Parameters to Evaluate:
kcat: Reflects the turnover number (catalytic efficiency)
Km: Indicates substrate binding affinity
kcat/Km: The specificity constant, best for comparing catalytic efficiency
Kd for HisH: Measures the strength of subunit interaction
Interpretation Framework:
Catalytic Residue Mutations:
Substantial decreases in kcat (>10-fold) with minimal changes in Km typically indicate disruption of catalytic machinery
Corresponding structural analysis should confirm that protein folding remains intact
Substrate Binding Mutations:
Increases in Km without significant changes in kcat suggest specific disruption of substrate binding
Double-reciprocal plots should be analyzed for competitive vs. non-competitive effects
Allosteric Site Mutations:
May show complex kinetic patterns with changes in both kcat and Km
Hill coefficients should be calculated to assess cooperative effects
Interface Mutations:
Primary effect often seen as increased Kd for HisH binding
Secondary effects on catalysis may indicate long-range conformational coupling
When interpreting these data, researchers should be aware that mutations can cause multiple effects, including subtle conformational changes that propagate through the protein structure. Complementary biophysical techniques such as circular dichroism and thermal denaturation should be employed to ensure that kinetic differences are not simply due to protein destabilization .
Crystallizing P. syringae HisF presents several challenges that researchers frequently encounter:
Problem: HisF may show time-dependent aggregation or degradation
Solution: Add 1-5% glycerol and 1 mM DTT to all buffers; maintain samples at 4°C; consider fusion tags that enhance stability (e.g., MBP)
Problem: Difficulty obtaining initial crystal hits
Solution: Implement microseed matrix screening (MMS) using crystals of homologous proteins; try streak-seeding; explore reductive methylation of surface lysines
Problem: Crystals often diffract to limited resolution (>3 Å)
Solution: Post-crystallization treatments with dehydration or annealing; try crystal growth at lower temperatures (4-10°C)
Problem: Molecular replacement may fail due to conformational differences
Solution: Prepare selenomethionine-labeled protein for experimental phasing; consider heavy atom soaking with iodide or platinum compounds
Optimal Crystallization Strategy:
Initial screening at 10-15 mg/mL protein concentration using commercial sparse matrix screens
Focus on conditions containing PEG 3350-8000 (10-20%) with pH range 6.5-8.5
Include 5-20 mM MgCl₂ to stabilize the active site
Consider co-crystallization with substrate analogs or product molecules
Explore the addition of the binding partner HisH for complex crystallization
This systematic approach typically yields diffraction-quality crystals within 1-3 months of optimization efforts, with successful structures typically refined to 1.8-2.5 Å resolution.
Analyzing the HisF-HisH interaction in P. syringae requires a multi-technique approach to fully characterize this functionally important protein-protein interface:
Biophysical Interaction Analysis:
Isothermal Titration Calorimetry (ITC):
Provides direct measurement of binding affinity (Kd), stoichiometry (n), and thermodynamic parameters (ΔH, ΔS)
Typical experimental conditions: 20-50 μM HisF in cell, 200-500 μM HisH in syringe
Expected Kd range: 100-500 nM for wild-type interaction
Surface Plasmon Resonance (SPR):
Measures real-time binding kinetics (kon, koff)
Immobilize His-tagged HisF on NTA sensor chip; flow HisH as analyte
Analyze association/dissociation phases separately to identify multi-step binding mechanisms
Microscale Thermophoresis (MST):
Requires minimal sample consumption
Label HisF with fluorescent dye and titrate with unlabeled HisH
Particularly useful for rapid screening of interface mutants
Structural Characterization:
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Maps regions of HisF that become protected upon HisH binding
Typically identifies not only direct interface residues but also allosteric networks
Cross-linking Mass Spectrometry (XL-MS):
Using BS3 or EDC cross-linkers to identify specific residue pairs at the interface
Provides distance constraints for molecular modeling
Cryo-Electron Microscopy:
For challenging cases where crystallization of the complex fails
May reveal conformational heterogeneity not captured by crystallography
Functional Analysis:
Allosteric Communication:
Enzyme kinetics with various substrate/product combinations
Single-molecule FRET to detect conformational changes upon complex formation
Mutagenesis Strategy:
Alanine scanning of predicted interface residues
Charge reversal mutations to disrupt salt bridges
Measure effects on binding affinity and catalytic parameters
When properly integrated, these approaches provide a comprehensive understanding of the structural basis for the functional interdependence between HisF and HisH in the bienzyme complex, revealing potential species-specific interaction motifs that could be exploited for selective inhibitor design.
Recombinant P. syringae HisF offers several promising applications in biosensor development, leveraging its unique structural and functional properties:
Biosensor Applications:
Metabolite Detection Systems:
HisF can be engineered as a specific recognition element for detecting PRFAR or related metabolites
Signal transduction can be achieved through fluorescent protein fusions that undergo conformational change upon substrate binding
Sensitivity range: typically 1-100 μM with optimization of protein engineering
Environmental Monitoring:
Modified HisF variants can detect histidine pathway inhibitors in agricultural settings
Application in screening for herbicide residues that target amino acid biosynthesis
Integration with portable detection systems for field use
Protein-Protein Interaction Sensing:
The HisF-HisH interface can be adapted to create split-reporter systems
Useful for high-throughput screening of compounds that disrupt protein-protein interactions
Can be applied in yeast two-hybrid or bacterial two-hybrid formats
Implementation Strategy:
Development of effective HisF-based biosensors requires rational protein engineering approaches:
Structure-guided insertion of reporter domains at positions that experience conformational changes
Optimization of linker sequences to maximize signal transduction efficiency
Directed evolution to enhance specificity and sensitivity for target analytes
The most successful applications to date have utilized the conformational changes in the C-terminal face of the TIM barrel that occur upon substrate binding or HisH interaction. These biosensors typically achieve detection limits in the micromolar range with response times of 1-5 minutes.
The evolutionary history of HisF in P. syringae pathovars can be studied through several emerging approaches that integrate genomic, phylogenetic, and structural analysis:
Comparative Genomics Approaches:
Pan-genome Analysis:
Positive Selection Analysis:
Calculating dN/dS ratios to identify residues under selection pressure
Using branch-site models to detect lineage-specific selection
Expected pattern: strong purifying selection on catalytic residues with possible positive selection at interface regions
Horizontal Gene Transfer Detection:
Analysis of GC content, codon usage bias, and phylogenetic incongruence
Assessment of genomic context conservation across pathovars
Identification of potential recombination breakpoints using methods like GARD or RDP4
Advanced Evolutionary Analysis:
Ancestral Sequence Reconstruction:
Inferring the sequence of HisF in the last common ancestor of P. syringae pathovars
Resurrecting ancestral proteins through recombinant expression
Comparing biochemical properties of ancestral and extant enzymes to trace functional evolution
Co-evolutionary Analysis:
Detecting co-evolving residues between HisF and HisH using methods like PSICOV or DCA
Mapping co-evolutionary networks onto structural models
Identifying coordinated evolutionary changes that maintain protein-protein interfaces
Experimental Evolution:
Subjecting P. syringae to histidine limitation stress over hundreds of generations
Sequencing evolved strains to identify adaptive mutations in hisF
Characterizing the effects of these mutations on enzyme function and bacterial fitness
These approaches, when integrated, provide a comprehensive view of how HisF has evolved within the P. syringae species complex, potentially revealing adaptations to different plant hosts and environmental conditions that could inform both fundamental understanding and applied research in plant pathology.
Computational approaches for predicting substrate specificity and catalytic efficiency of P. syringae HisF variants have advanced significantly, offering researchers powerful tools for rational enzyme engineering:
Structure-Based Computational Methods:
Molecular Dynamics (MD) Simulations:
All-atom simulations (typically 100-500 ns) to analyze conformational dynamics
Enhanced sampling techniques like accelerated MD or replica exchange to access rare conformational states
Analysis of hydrogen bonding networks, water-mediated interactions, and correlated motions
Computational cost: ~500-1000 CPU hours per variant on standard HPC resources
Quantum Mechanics/Molecular Mechanics (QM/MM):
Hybrid method treating the active site at quantum level while rest of protein uses molecular mechanics
Allows modeling of bond breaking/forming events in the catalytic mechanism
Calculation of activation energy barriers correlates well with experimental kcat values
Best results obtained using DFT methods (B3LYP/6-31G* level) for QM region
Ensemble Docking:
Uses multiple protein conformations extracted from MD simulations
Incorporates protein flexibility more effectively than rigid docking
Improves prediction of binding modes for substrate and transition state analogs
Machine Learning Approaches:
Sequence-Based Prediction:
Graph neural networks trained on enzyme superfamily sequence-function relationships
Feature extraction using position-specific scoring matrices and evolutionary couplings
Typical performance: R² = 0.70-0.85 for kcat prediction within enzyme families
Structure-Based Prediction:
3D convolutional neural networks analyzing active site geometry
Integration of electrostatic and hydrophobic interaction maps
Feature importance analysis for identifying critical residues
Transfer Learning Models:
Pre-trained on large enzyme datasets and fine-tuned for HisF-specific prediction
Incorporation of reaction mechanism knowledge as biased features
Cross-validation using experimental mutagenesis data
Integrated Workflow for Optimal Prediction:
The most effective strategy combines multiple computational approaches:
Initial screening of variants using fast sequence-based ML methods
Refinement of top candidates using MD simulations
Detailed energetic analysis of promising mutations using QM/MM
Experimental validation of top 5-10 predicted variants
This integrated approach typically achieves prediction accuracy of catalytic efficiency (kcat/Km) within 5-10 fold of experimental values for conservative mutations and 10-50 fold for more radical substitutions, providing a valuable tool for rational design of HisF variants with desired properties.
Recent advances in understanding P. syringae HisF function and applications have expanded our knowledge in several key areas:
Structural Biology Breakthroughs:
High-resolution structures of the complete HisF-HisH bienzyme complex have revealed dynamic conformational changes during the catalytic cycle
Neutron diffraction studies have mapped proton transfer networks essential for ammonia channeling
Cryo-EM analysis has captured intermediates previously inaccessible to crystallography
Systems Biology Integration:
Metabolic flux analysis has positioned HisF at a critical junction connecting amino acid and nucleotide metabolism in P. syringae
Transcriptomic studies have revealed differential expression of hisF during specific phases of plant infection
Proteome-wide interaction mapping has identified unexpected protein partners beyond HisH
Technological Applications:
Development of HisF-based biosensors for environmental monitoring
Engineering of HisF variants with enhanced thermostability for biocatalytic applications
Design of selective inhibitors targeting the HisF-HisH interface as potential antimicrobials
These advances have been facilitated by technological improvements in structural biology, computational modeling, and high-throughput experimental methods. The integration of these diverse approaches has provided a more comprehensive understanding of HisF's role in both bacterial metabolism and pathogenesis, opening new avenues for both fundamental research and applied biotechnology.
Despite significant progress, several key questions remain unanswered in P. syringae HisF research:
Mechanistic Questions:
How do conformational dynamics coordinate catalysis between the HisF and HisH active sites?
What is the precise path of ammonia channeling through the protein complex?
How do allosteric signals propagate between distant sites in the enzyme?
Physiological Questions:
How does histidine biosynthesis integrate with virulence-associated metabolic networks?
Does HisF activity respond to plant-derived signals during infection?
What is the relationship between histidine availability and expression of pathogenicity factors?
Evolutionary Questions:
How has the HisF-HisH interface co-evolved across different P. syringae pathovars?
Are there host-specific adaptations in HisF function among strains with different plant preferences?
What selective pressures drive HisF sequence conservation despite diverse ecological niches?
Applied Research Gaps:
Can HisF inhibitors be developed with sufficient specificity to target P. syringae without affecting beneficial microbes?
What structural features could be exploited to create pathovar-specific inhibitors?
How can HisF engineering be leveraged for developing environmentally friendly crop protection strategies?
Addressing these questions will require interdisciplinary approaches combining structural biology, biochemistry, molecular genetics, plant pathology, and computational biology. The answers will not only enhance our fundamental understanding of enzyme function and evolution but may also lead to novel strategies for managing plant diseases caused by P. syringae.
Research on P. syringae HisF has broader implications that extend beyond this specific enzyme system:
Models for Metabolic Adaptation:
HisF provides a well-defined system for studying how core metabolic enzymes adapt to the nutritional landscape of different plant hosts
Comparative studies across pathovars with different host ranges can reveal metabolic signatures of host adaptation
Understanding metabolic requirements during infection can identify new vulnerability points in bacterial pathogens
Enzyme-Engineering Principles:
The TIM barrel fold of HisF represents one of nature's most versatile enzyme scaffolds
Structure-function studies reveal fundamental principles of enzyme evolution and engineering
Insights gained can be applied to designing novel biocatalysts for biotechnological applications
Protein-Protein Interaction Networks:
The HisF-HisH interface exemplifies how protein-protein interactions can create emergent catalytic properties
Studies of this interface contribute to understanding molecular recognition principles
Methodologies developed can be applied to other protein complexes in various bacterial systems
Antimicrobial Development Strategy:
HisF research provides a template for targeting metabolic bottlenecks in bacterial pathogens
The approach of inhibiting protein-protein interfaces rather than active sites offers new possibilities for antimicrobial specificity
Lessons learned can inform discovery efforts for other plant, animal, and human pathogens